TY - JOUR
T1 - Post-Acute Pancreatitis Pancreatic Exocrine Insufficiency
T2 - Rationale and Methodology of a Prospective, Observational, Multicenter Cohort Study
AU - Paragomi, Pedram
AU - Phillips, Anna Evans
AU - Machicado, Jorge D.
AU - Lahooti, Ali
AU - Kamal, Ayesha
AU - Afghani, Elham
AU - Pothoulakis, Ioannis
AU - Reynolds, Shari L.
AU - Mays, Melanie
AU - Conwell, Darwin L.
AU - Lara, Luis F.
AU - Singh, Vikesh K.
AU - Papachristou, Georgios I.
N1 - Funding Information:
Financial support was provided by AbbVie Pharmaceuticals.
Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Objectives We describe the methodology of Post-Acute Pancreatitis Pancreatic Exocrine Insufficiency (PAPPEI), a prospective, observational, multicenter cohort study. The objectives of PAPPEI are to estimate the incidence rate of post-acute pancreatitis (AP) pancreatic exocrine insufficiency (PEI), define factors that determine the development of post-AP PEI, and evaluate the impact of post-AP PEI on nutritional status and quality of life. Methods Enrollment started in June 2017 in 3 expert academic centers in the United States. Data were collected during hospitalization (baseline) at 3 and 12 months after enrollment. Fecal elastase-1 was used to assess PEI. Study questionnaires are completed by patient interview and review of electronic medical records. Blood is obtained to evaluate vitamin deficiencies and nutritional markers. Results As of August 2020, 77 subjects have completed the baseline evaluation. The median age was 58 years (interquartile range, 39-67 years), 38% were male, and 90% were white. The etiology of AP was biliary in 39 subjects (51%), and 51 subjects (66%) had mild AP. Three- and 12-month follow-up data have been collected in 29 and 13 subjects, respectively. Conclusion The PAPPEI study aims to expand our understanding of post-AP PEI incidence, including its impact on nutritional status and quality of life.
AB - Objectives We describe the methodology of Post-Acute Pancreatitis Pancreatic Exocrine Insufficiency (PAPPEI), a prospective, observational, multicenter cohort study. The objectives of PAPPEI are to estimate the incidence rate of post-acute pancreatitis (AP) pancreatic exocrine insufficiency (PEI), define factors that determine the development of post-AP PEI, and evaluate the impact of post-AP PEI on nutritional status and quality of life. Methods Enrollment started in June 2017 in 3 expert academic centers in the United States. Data were collected during hospitalization (baseline) at 3 and 12 months after enrollment. Fecal elastase-1 was used to assess PEI. Study questionnaires are completed by patient interview and review of electronic medical records. Blood is obtained to evaluate vitamin deficiencies and nutritional markers. Results As of August 2020, 77 subjects have completed the baseline evaluation. The median age was 58 years (interquartile range, 39-67 years), 38% were male, and 90% were white. The etiology of AP was biliary in 39 subjects (51%), and 51 subjects (66%) had mild AP. Three- and 12-month follow-up data have been collected in 29 and 13 subjects, respectively. Conclusion The PAPPEI study aims to expand our understanding of post-AP PEI incidence, including its impact on nutritional status and quality of life.
KW - acute pancreatitis
KW - malnutrition
KW - pancreatic exocrine insufficiency
KW - steatorrhea
UR - http://www.scopus.com/inward/record.url?scp=85101472226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101472226&partnerID=8YFLogxK
U2 - 10.1097/MPA.0000000000001743
DO - 10.1097/MPA.0000000000001743
M3 - Article
C2 - 33565790
AN - SCOPUS:85101472226
SN - 0885-3177
VL - 50
SP - 147
EP - 152
JO - Pancreas
JF - Pancreas
IS - 2
ER -